Literature DB >> 19444307

Autoimmune T cell responses in the central nervous system.

Joan Goverman1.   

Abstract

Autoreactive T cell responses have a crucial role in central nervous system (CNS) diseases such as multiple sclerosis. Recent data indicate that CNS autoimmunity can be mediated by two distinct lineages of CD4+ T cells that are defined by the production of either interferon-gamma or interleukin-17. The activity of these CD4+ T cell subsets within the CNS influences the pathology and clinical course of disease. New animal models show that myelin-specific CD8+ T cells can also mediate CNS autoimmunity. This Review focuses on recent progress in delineating the pathogenic mechanisms, regulation and interplay between these different T cell subsets in CNS autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444307      PMCID: PMC2813731          DOI: 10.1038/nri2550

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  144 in total

1.  Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes.

Authors:  Amit Saxena; Jan Bauer; Tanja Scheikl; Jacques Zappulla; Marc Audebert; Sabine Desbois; Ari Waisman; Hans Lassmann; Roland S Liblau; Lennart T Mars
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

2.  Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.

Authors:  Jason R Lees; Yoichiro Iwakura; John H Russell
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

3.  CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells.

Authors:  Muhaimin Rifa'i; Zhe Shi; Shu-Yun Zhang; Young Ho Lee; Hiroshi Shiku; Ken-Ichi Isobe; Haruhiko Suzuki
Journal:  Int Immunol       Date:  2008-05-20       Impact factor: 4.823

4.  Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis.

Authors:  Samantha L Bailey-Bucktrout; Sarah C Caulkins; Gwendolyn Goings; Jens A A Fischer; Andrzej Dzionek; Stephen D Miller
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

5.  CD8+ T cells maintain tolerance to myelin basic protein by 'epitope theft'.

Authors:  Antoine Perchellet; Ingunn Stromnes; Jennifer M Pang; Joan Goverman
Journal:  Nat Immunol       Date:  2004-05-16       Impact factor: 25.606

Review 6.  The biology of interleukin-2.

Authors:  Thomas R Malek
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

7.  Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis.

Authors:  Xin Zhang; Yunan Tang; Danuta Sujkowska; Jinzhao Wang; Vinod Ramgolam; Mireia Sospedra; Jeremy Adams; Roland Martin; Clemencia Pinilla; Silva Markovic-Plese
Journal:  Eur J Immunol       Date:  2008-05       Impact factor: 5.532

8.  Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.

Authors:  Mandy J McGeachy; Leigh A Stephens; Stephen M Anderton
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

9.  Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.

Authors:  Dror Luger; Phyllis B Silver; Jun Tang; Daniel Cua; Zoe Chen; Yoichiro Iwakura; Edward P Bowman; Nicole M Sgambellone; Chi-Chao Chan; Rachel R Caspi
Journal:  J Exp Med       Date:  2008-04-07       Impact factor: 14.307

10.  IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.

Authors:  Mark A Kroenke; Thaddeus J Carlson; Anuska V Andjelkovic; Benjamin M Segal
Journal:  J Exp Med       Date:  2008-06-23       Impact factor: 14.307

View more
  403 in total

1.  Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain-Barré syndrome patients.

Authors:  Mohan S Maddur; Magalie Rabin; Pushpa Hegde; Francis Bolgert; Moneger Guy; Jean-Michel Vallat; Laurent Magy; Jagadeesh Bayry; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system.

Authors:  Roxana del Rio; Rajkumar Noubade; Naresha Saligrama; Emma H Wall; Dimitry N Krementsov; Matthew E Poynter; James F Zachary; Robin L Thurmond; Cory Teuscher
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

3.  Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase.

Authors:  Sourojit Bhowmick; Robert B Clark; Stefan Brocke; Robert E Cone
Journal:  Int Immunol       Date:  2011-01-27       Impact factor: 4.823

4.  Inflammatory cytokines determine the susceptibility of human CD8 T cells to Fas-mediated activation-induced cell death through modulation of FasL and c-FLIP(S) expression.

Authors:  Anna von Rossum; Randall Krall; Nichole K Escalante; Jonathan C Choy
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

5.  The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF.

Authors:  Mohamed El-Behi; Bogoljub Ciric; Hong Dai; Yaping Yan; Melissa Cullimore; Farinaz Safavi; Guang-Xian Zhang; Bonnie N Dittel; Abdolmohamad Rostami
Journal:  Nat Immunol       Date:  2011-04-24       Impact factor: 25.606

6.  Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides.

Authors:  Katherina Siewert; Joachim Malotka; Naoto Kawakami; Hartmut Wekerle; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Nat Med       Date:  2012-05       Impact factor: 53.440

Review 7.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

8.  Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.

Authors:  Yudong Liu; Andrew T Holdbrooks; Patrizia De Sarno; Amber L Rowse; Lora L Yanagisawa; Braden C McFarland; Laurie E Harrington; Chander Raman; Steffanie Sabbaj; Etty N Benveniste; Hongwei Qin
Journal:  J Immunol       Date:  2013-12-09       Impact factor: 5.422

9.  Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels.

Authors:  Marta Pedreño; Maria Morell; Gema Robledo; Luciana Souza-Moreira; Irene Forte-Lago; Marta Caro; Francisco O'Valle; Doina Ganea; Elena Gonzalez-Rey
Journal:  Brain Behav Immun       Date:  2013-12-07       Impact factor: 7.217

10.  Combinatorial Effect of Metformin and Lovastatin Impedes T-cell Autoimmunity and Neurodegeneration in Experimental Autoimmune Encephalomyelitis.

Authors:  Ajaib S Paintlia; Sarumathi Mohan; Inderjit Singh
Journal:  J Clin Cell Immunol       Date:  2013-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.